Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AstraZeneca PLC (GB:AZN)
LSE:AZN
Holding GB:AZN?
Track your performance easily
See the Price Targets and Ratings of:
AZN Analyst Ratings
Moderate Buy
9 Buy
5 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AZN Stock 12 Month Forecast
Average Price Target
13,372.65p
▲(27.33% Upside)
| Highest Price Target18,000p | Average Price Target13,373p | Lowest Price Target10,500p |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
Reiterated
11/22/24
Barclays
Assigned
11/22/24
Berenberg Bank
Reiterated
11/19/24
Bernstein
Reiterated
11/14/24
Deutsche Bank
Reiterated
11/13/24
DZ BANK AG
Reiterated
11/13/24
Stifel Nicolaus
Reiterated
11/13/24
Jefferies
Reiterated
11/12/24
Kepler Capital
Reiterated
11/12/24
Goldman Sachs
16,046p
Buy
52.79%
Upside
Reiterated
11/12/24
Goldman Sachs Sticks to Their Buy Rating for AstraZeneca (AZN)
Bank of America Securities
14,500p
Buy
38.07%
Upside
Reiterated
11/06/24
AstraZeneca's Promising Obesity Treatment Advances Justify Buy Rating: Analyst Report
Citi
14,000p
Buy
33.31%
Upside
Reiterated
09/30/24
Citi Sticks to Their Buy Rating for AstraZeneca (AZN)
Nordea Markets
10,698.47p
Sell
1.87%
Upside
Downgraded
09/11/24
AstraZeneca downgraded to Sell from Hold at NordeaAstraZeneca downgraded to Sell from Hold at Nordea
TD Cowen
14,860p
Buy
41.50%
Upside
Reiterated
08/11/24
We took another look at our AZN model as we approach the midpoint of Q3. We raised estimates in each year through 2030, reflecting growth that is above the industry average, yet we still are below management's 2030 revenue target. All told, AZN appears to have much business momentum and news upcoming, and as such we rate the stock Buy.
Best Analysts Covering AstraZeneca
Which Analyst Should I Follow If I Want to Buy GB:AZN and Sell After:
1 Month
xxx
Success Rate
10/17 ratings generated profit
Average Return
+1.72%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 58.82% of your transactions generating a profit, with an average return of +1.72% per trade.
3 Months
xxx
Success Rate
11/17 ratings generated profit
Average Return
+5.09%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +5.09% per trade.
1 Year
Success Rate
28/38 ratings generated profit
Average Return
+9.76%
assigned a buy rating 20 hours ago
Copying Emily Field's trades and holding each position for 1 Year would result in 73.68% of your transactions generating a profit, with an average return of +9.76% per trade.
2 Years
xxx
Success Rate
36/59 ratings generated profit
Average Return
+14.16%
reiterated a xxx
rating 20 hours ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 61.02% of your transactions generating a profit, with an average return of +14.16% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AZN Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
0
0
1
1
2
Buy
38
28
34
23
31
Hold
11
9
9
5
9
Sell
3
2
3
2
2
Strong Sell
1
1
3
3
5
total
53
40
50
34
49
Each month's total comprises the sum of three months' worth of ratings.
AZN Financial Forecast
AZN Stock Forecast FAQ
What is GB:AZN’s average 12-month price target, according to analysts?
Based on analyst ratings, AstraZeneca PLC’s 12-month average price target is 13,372.65p.
What is GB:AZN’s upside potential, based on the analysts’ average price target?
AstraZeneca PLC has 27.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AstraZeneca PLC a Buy, Sell or Hold?
AstraZeneca PLC has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 5 hold ratings and 1 sell ratings.
What is AstraZeneca PLC’s share price target?
The average share price target for AstraZeneca PLC is 13,372.65p. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 18,000.00p ,and the lowest forecast is 10,500.00p. The average share price target represents 27.33% Increase from the current price of 10,502p.
The highest analyst share price target is 18,000.00p ,and the lowest forecast is 10,500.00p. The average share price target represents 27.33% Increase from the current price of 10,502p.
What do analysts say about AstraZeneca PLC?
AstraZeneca PLC’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of AstraZeneca PLC?
To buy shares of GB:AZN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.